CSIMarket
 


Oragenics Inc   (OGEN)
Other Ticker:  
 
 

OGEN's Revenue Growth by Quarter and Year

Oragenics Inc 's Revenue results by quarter and year




OGEN Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.00 0.09 0.00
III Quarter September - 0.09 0.00 0.00
II Quarter June 0.01 0.03 0.00 0.00
I Quarter March 0.02 0.02 0.00 0.00
FY   0.03 0.14 0.09 0.00



OGEN Revenue second quarter 2023 Y/Y Growth Comment
Oragenics Inc reported drop in Revenue in the second quarter 2023 by -56.12% to $ 0.01 millions, from the same quarter in 2022.
The fall in the second quarter 2023 Oragenics Inc 's Revenue compares unfavorably to the Company's average Revenue decline of -21.48%.

Looking into second quarter 2023 results within Major Pharmaceutical Preparations industry 226 other companies have achieved higher Revenue growth. While Oragenics Inc ' s Revenue meltdown of -56.12% ranks overall at the positon no. 3925 in the second quarter 2023.




OGEN Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June -56.12 % - - -
I Quarter March 0 % - - -
FY   - 55.56 % - -

Financial Statements
Oragenics Inc 's second quarter 2023 Revenue $ 0.01 millions OGEN's Income Statement
Oragenics Inc 's second quarter 2022 Revenue $ 0.03 millions Quarterly OGEN's Income Statement
New: More OGEN's historic Revenue Growth >>


OGEN Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - 200 % - -
II Quarter June -34.19 % 50 % - -
I Quarter March - -77.78 % - -
FY (Year on Year)   - 55.56 % - -




Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #227
Healthcare Sector #598
Overall #3925

Revenue Y/Y Growth Statistics
High Average Low
81.16 % -21.48 % -100 %
(Jun 30 2014)   (Dec 31 2022)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #227
Healthcare Sector #598
Overall #3925
Revenue Y/Y Growth Statistics
High Average Low
81.16 % -21.48 % -100 %
(Jun 30 2014)   (Dec 31 2022)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Oragenics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
183.13 % 4 % -100 %
(Sep 30 2022)  


OGEN's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Oragenics Inc disclosed fall in Revenue from the first quarter by -34.19% to $ 0.01 millions, from $ 0.02 millions declared in the previous quarter.

Although cyclical influence normally elevate II. Quarter 2023 performance, that clearly was not enough to salvage Major Pharmaceutical Preparations's company performance, Juni Gustafsson, market advisor pointed out and wrote that average sequential Revenue growth is at 4% for the Major Pharmaceutical Preparations's company.

Within Major Pharmaceutical Preparations industry 243 other companies have achieved higher Revenue quarter on quarter growth. While Oragenics Inc 's Revenue growth quarter on quarter, overall rank is 4050.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #244
Healthcare Sector #640
Overall #4050
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #244
Healthcare Sector #640
Overall #4050
Revenue Q/Q Growth Statistics
High Average Low
183.13 % 4 % -100 %
(Sep 30 2022)  


OGEN's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Oragenics Inc reported fall in Revenue from the previous quarter by -34.19% to $ 0.01 millions, from $ 0.02 millions declared in the previous reporting period.

Even seasonal influence were not able to salvage the II. Quarter for the Oragenics Inc , Juni Gustafsson, market advisor pointed out, she cited little skepticism towards OGEN's direction.

Within Major Pharmaceutical Preparations industry 243 other companies have achieved higher Revenue quarter on quarter growth. While Oragenics Inc 's Revenue growth quarter on quarter, overall rank is 4050.


Oragenics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.22 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Jun 30 2023 period, Oragenics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Oragenics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2023 period, Oragenics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Oragenics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OGEN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for OGEN's Competitors
Revenue Growth for Oragenics Inc 's Suppliers
Revenue Growth for OGEN's Customers

You may also want to know
OGEN's Annual Growth Rates OGEN's Profitability Ratios OGEN's Asset Turnover Ratio OGEN's Dividend Growth
OGEN's Roe OGEN's Valuation Ratios OGEN's Financial Strength Ratios OGEN's Dividend Payout Ratio
OGEN's Roa OGEN's Inventory Turnover Ratio OGEN's Growth Rates OGEN's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Aquestive Therapeutics Inc -0.18%$ -0.181 millions
Phibro Animal Health Corporation-0.34%$ -0.340 millions
Procyon Corporation-0.59%$ -0.589 millions
Amedisys Inc -0.88%$ -0.882 millions
Baxter International Inc -1.04%$ -1.041 millions
Healthcare Services Group Inc -1.39%$ -1.395 millions
Bio rad Laboratories Inc -1.54%$ -1.536 millions
Harvard Bioscience Inc-1.83%$ -1.832 millions
Embecta Corp -1.92%$ -1.924 millions
Enhabit Inc -2.13%$ -2.127 millions
Icu Medical Inc-2.26%$ -2.260 millions
Tandem Diabetes Care Inc -2.26%$ -2.261 millions
West Pharmaceutical Services Inc -2.27%$ -2.269 millions
Coherus Biosciences inc -2.39%$ -2.386 millions
Hookipa Pharma inc -2.44%$ -2.440 millions
Biolife Solutions Inc -2.53%$ -2.529 millions
Enanta Pharmaceuticals Inc-3.01%$ -3.014 millions
National Research Corporation-3.03%$ -3.033 millions
Intellia Therapeutics Inc -3.11%$ -3.108 millions
Orgenesis Inc -3.14%$ -3.138 millions
Organogenesis Holdings Inc -3.36%$ -3.365 millions
Marker Therapeutics inc -3.52%$ -3.523 millions
Akumin Inc -3.79%$ -3.793 millions
Endo International Plc-3.91%$ -3.912 millions
Zimvie Inc -4.12%$ -4.122 millions
Integra Lifesciences Holdings Corp-4.16%$ -4.160 millions
Universal Biosensors Inc -4.18%$ -4.177 millions
Sonendo Inc -4.26%$ -4.257 millions
Avinger Inc -4.27%$ -4.268 millions
Fuse Medical Inc -4.27%$ -4.271 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com